Retatrutide, from Soma Corp., is attracting considerable attention as a innovative method for weight control . This unique medication integrates the properties of a GLP-1 receptor stimulant and a GIP receptor agonist , aiming to not only promote reduced body fat but also address related metabolic issues . Early patient data have shown encouraging o